Navigation Links
NHP Reports Fourth Quarter and Full Year 2007 Earnings
Date:2/25/2008

- 2007 INVESTMENTS TOTAL $1.1 BILLION

- 2008 DIVIDEND INCREASED 7.3%

- ANNUAL REVENUES INCREASED 34.5%

- NORMALIZED ANNUAL FFO PER SHARE UP 7.8%

NEWPORT BEACH, Calif., Feb. 25 /PRNewswire-FirstCall/ -- Nationwide Health Properties, Inc. (NYSE: NHP) today announced its fourth quarter and full year 2007 operating results and investment activity.

"We ended 2007 on a strong note with fourth quarter revenues up 29.1% and normalized FFO per share up 12.5% over fourth quarter 2006 which enabled us to increase our quarterly per share dividend in January 2008 by $0.03, or $0.12 on an annual basis," commented Douglas M. Pasquale, NHP's President and Chief Executive Officer. "This has been a successful year for NHP, and the numbers clearly tell the tale. With $376 million of closed investments during the quarter bringing our total for the year to $1.1 billion, an increase in revenues for the year of 34.5%, an increase in normalized FFO per share of 7.8% and a $0.10 increase in the dividend over 2006, this was clearly a year of growth," Mr. Pasquale added.

2007 FOURTH QUARTER RESULTS

The following table presents selected financial results for the fourth quarter and full year 2007 as compared to the fourth quarter and full year 2006:

SELECTED FINANCIAL RESULTS

($ in thousands, except per share amounts)

Three Months Ended December 31,

Item 2007 2006 Change

Revenues $89,457 $69,291 $20,166 29.1%

Income from Continuing

Operations $41,935 $
'/>"/>

SOURCE Nationwide Health Properties, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine news :

1. High Calcium Intake May Not Help Prevent Fractures, Reports The Harvard Health Letter
2. Clarity for Consumers on Botox Complication and Death Reports
3. Neurochem reports results for fourth quarter and fiscal year 2007 and important advances on corporate objectives
4. Emageon Reports Fourth Quarter and 2007 Financial Results
5. Cyberonics Reports Operating Profit for Third Quarter FY08 and Announces Share Repurchase Program
6. Platinum Underwriters Holdings, Ltd. Reports Record Fourth Quarter and Year Ended December 31, 2007 Financial Results
7. Onyx Pharmaceuticals Reports Fourth Quarter and Twelve-Month 2007 Financial Results
8. Cambrex Reports Fourth Quarter and Full-Year 2007 Results
9. Shengtai Pharmaceutical, Inc. Reports Strong Second Quarter Results of Fiscal Year 2008
10. TeamStaff Reports First Quarter Net Income and $0.7 Million Income Improvement From Continuing Operations Over Prior Year
11. The Quantum Group Reports 4th Quarter and Year End Results for Fiscal Year 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/18/2014)... Santa Fe, NM (PRWEB) November 18, 2014 ... Elizabeth Showers , showcasing a special selection of her ... public is encouraged to stroll in to the gallery, Friday, ... Friday Art Walk in Santa Fe. , Showers artistic creations ... age and those memories continue to inspire her designs. She ...
(Date:11/18/2014)... Tara Haelle HealthDay Reporter ... of children who experience a severe abusive head trauma before ... according to a new study. In addition, among ... cut in half, the study found. Abusive head trauma ... is shaken and suffers head injuries, according to background information ...
(Date:11/18/2014)... By Dennis Thompson ... -- Otherwise healthy people on the verge of burning out ... research. Those suffering from so-called vital exhaustion -- a ... 36 percent increased risk of developing heart disease, researchers report. ... lot of stress. And I think, when that stress is ...
(Date:11/18/2014)... recently, insect-transmitted Chagas disease was found mainly in Latin America ... the United States over the past few years. ... of the "kissing bug," which feeds on the faces of ... common bedbugs might be carriers as well. "We,ve shown ... next step is to determine whether they are, or will ...
(Date:11/17/2014)... Vernon Brewer, Founder and President of World Help, ... and saw firsthand the devastating holocaust that ISIS is exacting ... Syria. , “‘Holocaust’ is not a term I use lightly, ... thousands of Christians and members of other faiths from their ... As ISIS expands, they continue to kill Christians and ...
Breaking Medicine News(10 mins):Health News:Elizabeth Showers Trunk Show & Personal Appearance Hosted by Sorrel Sky Gallery 2Health News:Head Trauma in Abused Babies, Toddlers Can Have Lifelong Impact 2Health News:Head Trauma in Abused Babies, Toddlers Can Have Lifelong Impact 3Health News:Head Trauma in Abused Babies, Toddlers Can Have Lifelong Impact 4Health News:Feeling 'Worn Out'? Your Heart May Pay the Price 2Health News:Feeling 'Worn Out'? Your Heart May Pay the Price 3Health News:Bedbugs Could Be Potential New Source of Tropical Disease in U.S. 2Health News:Bedbugs Could Be Potential New Source of Tropical Disease in U.S. 3Health News:President of WORLD HELP Travels to Iraq and Jordan; Finds Religious Holocaust Being Executed by ISIS 2Health News:President of WORLD HELP Travels to Iraq and Jordan; Finds Religious Holocaust Being Executed by ISIS 3
... death rate in New York City reached an all-time ... the number of deaths fell to 55,391 -- down ... declined in eight leading categories, including diabetes, HIV, chronic ... that increased significantly was substance use (up 8%). Heart ...
... bowel syndrome and lead to new treatments , , ... bowel syndrome anticipate and react to pain differently than ... The University of California, Los Angeles researchers found that ... modulation mechanism in the brain, which makes them more ...
... study suggests that removing the entire kidney from younger patients ... compared with an operation that removes the tumor but leaves ... February issue of the Journal of Urology. , Radical nephrectomy ... with the adrenal gland that sits atop the kidney and ...
... -Approval Makes Available New Daily Dosing Option for the ... Lilly and Company,(NYSE: LLY ) announced today that ... (tadalafil)(1) for once daily use (2.5 mg and,5 mg), ... erectile dysfunction,(ED). When Cialis for once daily use is ...
... 8 In 2006, 66% of Americans were,overweight or ... working in,seated sedentary jobs? Or do we prefer seated ... No one knows for sure, but Texas based Neutral,Posture ... this trend. Recently,Neutral Posture introduced the Ntune(TM) Seating System, ...
... NEW YORK, Jan. 8 Bristol-Myers Squibb ... Partners, a leading private equity firm,announced today ... Bristol-Myers,Squibb Medical Imaging, a business unit of ... a leading supplier of medical imaging,products for ...
Cached Medicine News:Health News:New York City death rate reaches historic low 2Health News:New York City death rate reaches historic low 3Health News:New York City death rate reaches historic low 4Health News:Women With IBS Unable to Switch Off Pain Response 2Health News:How less can be more when treating some kidney cancers 2Health News:FDA Approves Cialis(R) (tadalafil) for Once Daily Use for the Treatment of Erectile Dysfunction 2Health News:FDA Approves Cialis(R) (tadalafil) for Once Daily Use for the Treatment of Erectile Dysfunction 3Health News:FDA Approves Cialis(R) (tadalafil) for Once Daily Use for the Treatment of Erectile Dysfunction 4Health News:FDA Approves Cialis(R) (tadalafil) for Once Daily Use for the Treatment of Erectile Dysfunction 5Health News:Office Furniture That Helps Fight Fat! 2Health News:Avista Capital Partners Completes Acquisition of Bristol-Myers Squibb Medical Imaging 2
(Date:11/18/2014)... Ind. , Nov. 18, 2014  Zimmer Holdings, ... it has agreed with the European Commission (the "EC") ... Zimmer,s proposed acquisition of Biomet by a limited number ... certain additional information. Deadline extensions are ... working closely with the regulatory authorities to facilitate their ...
(Date:11/18/2014)... Nov. 18, 2014  Isis Pharmaceuticals, Inc. (NASDAQ: ... webcast on Monday, December 8, 2014 at 9:00 a.m. Eastern ... the 56 th American Society of Hematology Annual Meeting ... the call by dialing 877-443-5662 or access the webcast at ... a limited time at the same address. ...
(Date:11/18/2014)... -- AgeneBio, a pharmaceutical company developing innovative therapeutics that ... today announced that the Company,s founder and chief ... received the Society for Neuroscience,s Mika Salpeter Lifetime ... Gallagher,s research at Johns Hopkins and the University ... to advancements in the field of cognitive neuroscience ...
Breaking Medicine Technology:Zimmer Provides Update on the European Commission Review Process Relating to the Pending Merger with Biomet, Inc. 2Zimmer Provides Update on the European Commission Review Process Relating to the Pending Merger with Biomet, Inc. 3Zimmer Provides Update on the European Commission Review Process Relating to the Pending Merger with Biomet, Inc. 4Zimmer Provides Update on the European Commission Review Process Relating to the Pending Merger with Biomet, Inc. 5Isis Pharmaceuticals to Host Webcast to Discuss ISIS-FXI Rx Data Presented at the ASH Annual Meeting 2Isis Pharmaceuticals to Host Webcast to Discuss ISIS-FXI Rx Data Presented at the ASH Annual Meeting 3AgeneBio Founder and Chief Scientific Officer Receives Society for Neuroscience's Mika Salpeter Lifetime Achievement Award 2AgeneBio Founder and Chief Scientific Officer Receives Society for Neuroscience's Mika Salpeter Lifetime Achievement Award 3
... Improved Symptomatic Status, Cardiac Function and Reduced ... in both Functional and Degenerative MR Patient ... percutaneous mitral repair using the MitraClip(R) system ... functional mitral regurgitation (FMR) or degenerative mitral ...
... may provide meaningful clinical benefit in IPF patients -- ... -- Conference Call and Webcast at 9 p.m. EDT ... InterMune, Inc. (Nasdaq: ITMN ) reported that ... pirfenidone in patients with idiopathic pulmonary fibrosis (IPF) were ...
Cached Medicine Technology:MitraClip(R) Therapy Data Demonstrate Clinical Benefit in High-Risk Patients With Mitral Regurgitation 2MitraClip(R) Therapy Data Demonstrate Clinical Benefit in High-Risk Patients With Mitral Regurgitation 3MitraClip(R) Therapy Data Demonstrate Clinical Benefit in High-Risk Patients With Mitral Regurgitation 4Results of Two Phase 3 CAPACITY Studies of Pirfenidone in IPF Presented at American Thoracic Society (ATS) 2Results of Two Phase 3 CAPACITY Studies of Pirfenidone in IPF Presented at American Thoracic Society (ATS) 3Results of Two Phase 3 CAPACITY Studies of Pirfenidone in IPF Presented at American Thoracic Society (ATS) 4Results of Two Phase 3 CAPACITY Studies of Pirfenidone in IPF Presented at American Thoracic Society (ATS) 5Results of Two Phase 3 CAPACITY Studies of Pirfenidone in IPF Presented at American Thoracic Society (ATS) 6Results of Two Phase 3 CAPACITY Studies of Pirfenidone in IPF Presented at American Thoracic Society (ATS) 7Results of Two Phase 3 CAPACITY Studies of Pirfenidone in IPF Presented at American Thoracic Society (ATS) 8Results of Two Phase 3 CAPACITY Studies of Pirfenidone in IPF Presented at American Thoracic Society (ATS) 9Results of Two Phase 3 CAPACITY Studies of Pirfenidone in IPF Presented at American Thoracic Society (ATS) 10Results of Two Phase 3 CAPACITY Studies of Pirfenidone in IPF Presented at American Thoracic Society (ATS) 11Results of Two Phase 3 CAPACITY Studies of Pirfenidone in IPF Presented at American Thoracic Society (ATS) 12